SCHEMBL4873537

SCHEMBL4873537

COc1cccc(C2(NS(N)(=O)=O)CCN(c3ncccn3)CC2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.51
NPC1 O15118 1/20 0.51
ALDH1A1 P00352 3/20 0.47
HPGD P15428 2/20 0.47
KDM4E B2RXH2 6/20 0.46
GAA P10253 1/20 0.46
KMT2A Q03164 3/20 0.45
TSHR P16473 2/20 0.45
MEN1 O00255 1/20 0.45
TP53 P04637 1/20 0.45
CYP3A4 P08684 2/20 0.43
DRD2 P14416 1/20 0.43
DRD4 P21917 1/20 0.43
DRD3 P35462 1/20 0.43
USP2 O75604 1/20 0.43
CYP2D6 P10635 1/20 0.43
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4872826 0.85 ALDH1A1 (0.47) MAPTNPC1ALDH1A1HPGDKDM4E
SCHEMBL4878703 0.82 ALDH1A1 (0.45) MAPTNPC1ALDH1A1HPGDKDM4E
SCHEMBL4868393 0.81 ALDH1A1 (0.48) MAPTNPC1ALDH1A1HPGDKDM4E
SCHEMBL4876648 0.81 ALDH1A1 (0.47) MAPTNPC1ALDH1A1HPGDKDM4E
SCHEMBL4876628 0.81 ALDH1A1 (0.47) MAPTNPC1ALDH1A1HPGDKDM4E
SCHEMBL4873649 0.80 ALDH1A1 (0.56) MAPTNPC1ALDH1A1HPGDKDM4E
SCHEMBL4879768 0.79 ALDH1A1 (0.45) MAPTNPC1ALDH1A1HPGDKDM4E
SCHEMBL4870875 0.79 MAPT (0.60) MAPTNPC1ALDH1A1HPGDKDM4E
SCHEMBL4876701 0.79 ALDH1A1 (0.50) MAPTNPC1ALDH1A1HPGDKDM4E
Hydrochloric Acid SCHEMBL4873499 0.76 KDM1A (0.46) ALDH1A1KMT2AMEN1HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096922-A1 Novel Sulfonamide derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2008-04-24 US disclosed
EP-1736467-A1 NOVEL SULFONAMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2006-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096922-A1 Novel Sulfonamide derivative NR4A1, NR4A2, NR4A3 MAPT 4852/4885NPC1 239/4885ALDH1A1 2899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.